Tslp promotes immune evasion and persistence of viruses

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/715 (2006.01) A61K 38/17 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01) A61P 37/02 (2006.01) C07K 16/24 (2006.01) G01N 33/53 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2750988

The invention relates to the treatment or prevention of a chronic viral infection with a Thymic Stromal Lym-phopoietin (TSLP) antagonist thereby avoiding immune evasion and persistence of the virus. The invention also provides a method of prognosing the evolution of a cervical dysplasia by TSLP expression in a sample of said cervical dysplasia.

La présente invention porte sur le traitement ou la prévention d'une infection virale chronique par un antagoniste de la lymphopoïétine stromale thymique (TSLP), ce qui permet de cette manière d'éviter l'évasion immunitaire et la persistance du virus. L'invention porte également sur une méthode de pronostic de l'évolution d'une dysplasie cervicale par l'expression de la TSLP dans un échantillon de ladite dysplasie cervicale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tslp promotes immune evasion and persistence of viruses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tslp promotes immune evasion and persistence of viruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tslp promotes immune evasion and persistence of viruses will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1781561

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.